Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization
Clinical Interventions in Aging · 2025
DOI: 10.2147/cia.s547803 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Interventions in Aging, 2025. Verfasst von Shaotian Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Union Hospital TongJi Medical College HuaZhong University of Science and Technology, Wuhan, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Denosumab, Osteoporosis, RANK Ligand. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Union Hospital TongJi Medical College HuaZhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
- Geriatric hospital Affiliated to Wuhan University of science and technology, Wuhan, Hubei, People's Republic of China.
ORCID-Profile: Shaotian Li, Jingfeng Zou, Yiting Liu, Chunhui Tian, Jiajia Ran
Zitieren
APA
Li, S., Hu, S., Zheng, X., Ku, X., Zou, J., Wang, L., Nie, G., Liu, Y., Tian, C., Ran, J., Yang, X., Yan, M., Yin, Y., Liu, Y., Wan, J., & Peng, W. (2025). Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s547803
Vancouver
Li S, Hu S, Zheng X, Ku X, Zou J, Wang L, et al. Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization. Clinical Interventions in Aging. 2025. doi:10.2147/cia.s547803
BibTeX
@article{Li2025,
author = {Li, Shaotian and Hu, Shanshan and Zheng, Xiaoli and Ku, Xiong and Zou, Jingfeng and Wang, Liping and Nie, Guqiao and Liu, Yiting and Tian, Chunhui and Ran, Jiajia and Yang, Xin and Yan, Mi and Yin, Yilan and Liu, Yun and Wan, Jingjing and Peng, Wen},
title = {Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization},
journal = {Clinical Interventions in Aging},
year = {2025},
doi = {10.2147/cia.s547803}
}
EUVIMED